A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers
Clinical trial NCT07279636 · COMPLETED
Trial details
- NCT number
- NCT07279636
- Sponsor
- AlphaMol Science Ltd. (Shanghai)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-21
- Primary completion
- 2026-02-14
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.